UK study aims to crack the code of brain tumours with genetic testing
NCT ID NCT04274283
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This UK study is building a network to rapidly analyze the genetics of brain tumours (gliomas) from 1000 patients. By combining tumour and blood samples, researchers hope to classify each tumour more precisely. The goal is to create a system that can quickly match patients with the right targeted therapies in future trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could create a system to quickly identify the exact genetic makeup of brain tumours, making it easier to test and deliver personalized treatments.
What could go wrong
This is a feasibility study focused on building infrastructure, not testing a treatment. It may not directly improve outcomes for participants, and the hoped-for targeted therapy trials may not follow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
TERMINATEDCambridge, CB2 0QQ, United Kingdom
-
Charing Cross Hospital, Imperial College Healthcare NHS Trust
RECRUITINGLondon, W6 8RF, United Kingdom
Contact
-
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
RECRUITINGOxford, OX3 9DU, United Kingdom
Contact
-
Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust
RECRUITINGNewcastle upon Tyne, NE7 7DN, United Kingdom
Contact
-
King's College Hospital, King's College Hospital NHS Foundation Trust
RECRUITINGLondon, SE5 9RS, United Kingdom
Contact
-
NHS Lothian
ACTIVE_NOT_RECRUITINGEdinburgh, EH4 2XU, United Kingdom
-
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust
RECRUITINGBirmingham, B15 2TH, United Kingdom
Contact
-
Queen Elizabeth Unviersity Hospital, NHS Greater Glasgow and Clyde Health Board
ACTIVE_NOT_RECRUITINGGlasgow, G51 4TF, United Kingdom
-
Queen's Medical Centre, Nottingham University Hospitals NHS Trust
RECRUITINGNottingham, NG7 2UH, United Kingdom
Contact
-
Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust
RECRUITINGManchester, M6 8HD, United Kingdom
Contact
-
St James's University Hospital, Leeds Teaching Hospitals NHS Trust
RECRUITINGLeeds, LS9 7TF, United Kingdom
Contact
-
The Christie Hospital, The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
Contact
-
The Walton Centre, The Walton Centre NHS Foundation Trust
RECRUITINGLiverpool, L9 7LJ, United Kingdom
Contact
-
Velindre Cancer Centre, Velindre University NHS Trust
RECRUITINGCardiff, CF14 2TL, United Kingdom
Contact